231 related articles for article (PubMed ID: 15997234)
1. Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain.
Winkler I; Blotnik S; Shimshoni J; Yagen B; Devor M; Bialer M
Br J Pharmacol; 2005 Sep; 146(2):198-208. PubMed ID: 15997234
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of antiepileptic tetramethylcyclopropyl analogues of valproic acid amides in a rat model of neuropathic pain.
Winkler I; Sobol E; Yagen B; Steinman A; Devor M; Bialer M
Neuropharmacology; 2005 Dec; 49(8):1110-20. PubMed ID: 16055160
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid.
Kaufmann D; Yagen B; Minert A; Wlodarczyk B; Finnell RH; Schurig V; Devor M; Bialer M
Neuropharmacology; 2010 Jun; 58(8):1228-36. PubMed ID: 20230843
[TBL] [Abstract][Full Text] [Related]
4. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
Blotnik S; Bergman F; Bialer M
Drug Metab Dispos; 1996 May; 24(5):560-4. PubMed ID: 8723737
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues.
Kaufmann D; Bialer M; Shimshoni JA; Devor M; Yagen B
J Med Chem; 2009 Nov; 52(22):7236-48. PubMed ID: 19877649
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the enantioselective antiallodynic and pharmacokinetic profile of propylisopropylacetamide, a chiral isomer of valproic acid amide.
Kaufmann D; Yagen B; Minert A; Tal M; Devor M; Bialer M
Neuropharmacology; 2008 Mar; 54(4):699-707. PubMed ID: 18201732
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antiallodynic interaction between gabapentin or carbamazepine and either benfotiamine or cyanocobalamin in neuropathic rats.
Mixcoatl-Zecuatl T; Quinonez-Bastidas GN; Caram-Salas NL; Ambriz-Tututi M; Araiza-Saldana CI; Rocha-Gonzalez HI; Medina-Santillan R; Reyes-Garcia G; Granados-Soto V
Methods Find Exp Clin Pharmacol; 2008; 30(6):431-41. PubMed ID: 18850044
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs.
Bialer M
J Control Release; 1999 Nov; 62(1-2):187-92. PubMed ID: 10518650
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy.
Isoherranen N; White HS; Klein BD; Roeder M; Woodhead JH; Schurig V; Yagen B; Bialer M
Pharm Res; 2003 Aug; 20(8):1293-301. PubMed ID: 12948028
[TBL] [Abstract][Full Text] [Related]
10. Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
Okada A; Kurihara H; Aoki Y; Bialer M; Fujiwara M
Birth Defects Res B Dev Reprod Toxicol; 2004 Feb; 71(1):47-53. PubMed ID: 14991910
[TBL] [Abstract][Full Text] [Related]
11. Design and pharmacological activity of glycinamide and N-methoxy amide derivatives of analogs and constitutional isomers of valproic acid.
Pessah N; Yagen B; Hen N; Shimshoni JA; Wlodarczyk B; Finnell RH; Bialer M
Epilepsy Behav; 2011 Nov; 22(3):461-8. PubMed ID: 21959082
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of neuropathy-induced allodynia following intraplantar injection of pregabalin.
Park HJ; Joo HS; Chang HW; Lee JY; Hong SH; Lee Y; Moon DE
Can J Anaesth; 2010 Jul; 57(7):664-71. PubMed ID: 20440664
[TBL] [Abstract][Full Text] [Related]
13. New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
Isoherranen N; Yagen B; Bialer M
Curr Opin Neurol; 2003 Apr; 16(2):203-11. PubMed ID: 12644750
[TBL] [Abstract][Full Text] [Related]
14. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.
Honore P; Donnelly-Roberts D; Namovic MT; Hsieh G; Zhu CZ; Mikusa JP; Hernandez G; Zhong C; Gauvin DM; Chandran P; Harris R; Medrano AP; Carroll W; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1376-85. PubMed ID: 16982702
[TBL] [Abstract][Full Text] [Related]
15. Derivatives of valproic acid are active against pentetrazol-induced seizures in immature rats.
Mareš P; Kubová H; Hen N; Yagen B; Bialer M
Epilepsy Res; 2013 Sep; 106(1-2):64-73. PubMed ID: 23815889
[TBL] [Abstract][Full Text] [Related]
16. Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid.
Shimshoni JA; Bialer M; Wlodarczyk B; Finnell RH; Yagen B
J Med Chem; 2007 Dec; 50(25):6419-27. PubMed ID: 17994680
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects.
Bialer M; Haj-Yehia A; Barzaghi N; Pisani F; Perucca E
Eur J Clin Pharmacol; 1990; 38(3):289-91. PubMed ID: 2111246
[TBL] [Abstract][Full Text] [Related]
18. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid.
Radatz M; Ehlers K; Yagen B; Bialer M; Nau H
Epilepsy Res; 1998 Mar; 30(1):41-8. PubMed ID: 9551843
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic and pharmacokinetic analysis of CNS-active constitutional isomers of valnoctamide and sec-butylpropylacetamide--Amide derivatives of valproic acid.
Mawasi H; Shekh-Ahmad T; Finnell RH; Wlodarczyk BJ; Bialer M
Epilepsy Behav; 2015 May; 46():72-8. PubMed ID: 25863940
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide.
Bialer M; Hadad S; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Yagen B
Pharm Res; 1996 Feb; 13(2):284-9. PubMed ID: 8932450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
